Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
Addressing Cervical Cancer Disparity in South Florida: CBPR in Action
2 other identifiers
interventional
602
1 country
1
Brief Summary
The study will test the significance of community health worker (CHW) participation by comparing self-sampling provided by a community health worker and self-sampling provided by mail. The study will enroll 700 participants in communities that lack access to medical care in South Florida.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2014
CompletedFirst Posted
Study publicly available on registry
July 28, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedResults Posted
Study results publicly available
December 19, 2018
CompletedDecember 19, 2018
December 1, 2018
2.6 years
July 9, 2014
July 3, 2018
December 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Completing a Self-sampling Test
The primary outcome is having had a self-sampling done since the initial evaluation. Participants who test negative will be encouraged to rescreen while Participants who test positive for HPV will be navigated to appropriate follow-up care. The CHWs will follow up with participants who do not return the kit within 60 days.
2 to 6 months
Secondary Outcomes (2)
Proportion of Change in Cervical Cancer Knowledge Among Participants
Baseline, 6 months
Proportion of Participants With a Change in Access to Care
Baseline, 6 months
Study Arms (2)
CHWs facilitated Self-Sampling
ACTIVE COMPARATORCHW and Self-sampling for Cervical Cancer. Home visit, self-sampler, collection of test
Mailed Self-Sampler
ACTIVE COMPARATORMailed Self Sampler. Self sampler is mailed to participant; follow up by phone
Interventions
Behavioral: CHW and Self-sampling for Cervical Cancer The intervention strategies will involve one home visit: 1) provide brief health education on cervical cancer screening, 2) provide and collect self-sampler test. We envision visits lasting no more than 60 minutes.
Mailed Self Sampler. Women randomized to this intervention arm will receive a self-sampling kit via mail. This kit will include: 1) the self-sampler; 2) the vial for collecting and storing the specimen; 3) a pre-addressed, stamped envelope for returning the vial; 4) a brief introductory letter/postcard which includes a picture of the CHE and the CHW and serves to re-orient the participant to the focus of the study; 5) instructional guide that visually depicts the steps for self-sampling;
Eligibility Criteria
You may qualify if:
- Women
- Haitian, Hispanic, or African American
- Ages 30-65 years
- Report not having had a pap smear in the last three years live in the cities of Miami/Little Haiti, Hialeah or unincorporated Southern Miami-Dade
You may not qualify if:
- Women who report having had a hysterectomy
- Women who have a history of cervical cancer
- Women who plan to move outside of Miami-Dade county during the next six months
- Women who are enrolled in any other cancer prevention/outreach related study
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- Health Choice Networkcollaborator
- Center for Haitian Studiescollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
Related Publications (1)
Kobetz E, Seay J, Amofah A, Pierre L, Bispo JB, Trevil D, Gonzalez M, Poitevien M, Koru-Sengul T, Carrasquillo O. Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial. Trials. 2017 Jan 13;18(1):19. doi: 10.1186/s13063-016-1721-6.
PMID: 28086983DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Erin Kobetz
- Organization
- University of Miami
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Kobetz, PhD
University of Miami
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 9, 2014
First Posted
July 28, 2014
Study Start
January 1, 2015
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
December 19, 2018
Results First Posted
December 19, 2018
Record last verified: 2018-12